January 14, 2020
BERG is a biotech company that creates cancer drugs through A.I. and machine learning. Based on recent FDA meetings and discussions, BERG has two drug products moving towards Phase 3 development and other late stage assets in planning phases. Niven Narain, co-founder and CEO of BERG, joined Cheddar to discuss.